T-cell exhaustion in COVID-19: what do we know?

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• T-cell exhaustion is a state of immune dysfunction marked by impaired T-cell function and increased inhibitory receptor expression.
• In COVID-19, exhausted T-cell phenotypes correlate with severe disease, delayed viral clearance, and Long COVID symptoms.
• The coexistence of exhaustion and hyperactivation in COVID-19 raises questions about the reversibility of T-cell dysfunction.

Purpose of the Study:

• To review current understanding of T-cell exhaustion in COVID-19 immunopathology.
• To synthesize advances in therapeutic strategies targeting T-cell dysfunction.
• To identify critical research gaps in the study of T-cell exhaustion during COVID-19 and Long COVID.

Main Methods:

• Non-systematic literature review.
• Synthesis of current research on COVID-19 immunopathology.
• Analysis of therapeutic strategies for T-cell dysfunction.

Main Results:

• Prolonged stimulation in COVID-19 leads to T-cell exhaustion, characterized by specific molecular markers (PD-1, TIM-3, CTLA-4).
• Therapeutic strategies including immune checkpoint inhibitors and metabolic interventions are under investigation.
• Significant research gaps exist, including limited longitudinal data and incomplete T-cell subset profiling.

Conclusions:

• Understanding T-cell exhaustion is crucial for improving COVID-19 outcomes.
• Targeting T-cell dysfunction is essential for developing next-generation immunotherapies and vaccines.
• Further research is needed to clarify the role of T-cell exhaustion in vaccine responses and Long COVID.